Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Healthcare Geofencing: The What & Why

November 20, 2023

Healthcare geofencing campaigns use programmatic technology that leverages GPS signals from HCPs’ devices and delivers ads based on this data.

Photos of Sharron Rouse and Shoshana Lipson two of Health Union’s 2023 Social Health Award winners, at Digital Pharma East 2023

Patient Leader Perspectives: Co-Design with ‘Patients from the Start’

November 1, 2023

These two accomplished patient leaders combined their experiences and perspectives to explain how industry can integrate “patients from the start.”

A pair of hands hold up a photo of a couple ripped in half around them are rain drops with question marks in them and waves below

Understanding Rare Conditions: The Impact on Relationships

September 26, 2023

Findings from Health Union’s surveys of its rare condition communities show one’s relationships and social life can take significant hits.

NPI Targeting: 3 Reasons It’s a Healthcare Advertiser’s Best Friend

August 14, 2023

A 1:1 relationship with HCPs isn't a guarantee. NPI targeting significantly increases the likelihood that happens.

IBS Patient-Reported Survey Data 2020

October 19, 2020

Merely 9% of people living with IBS were currently taking a prescription IBS medication, according to new Health Union patient-reported survey data.

Alzheimer’s Disease Patient-Reported Survey Data | 2020

October 6, 2020

Only 11% of people living with Alzheimer’s disease feel controlled on their current treatment plan, according to Health Union patient-reported survey data.

COPD Patient-Reported Survey Data | 2020

September 23, 2020

44% of people living with COPD who experience pain consider themselves as having chronic pain, according to new Health Union survey data.

Multiple Sclerosis Patient-Reported Survey Data | 2020

September 10, 2020

71% of people living with multiple sclerosis currently use a DMT but many live with pain and emotional grief, according to new Health Union survey data.

Healthcare Industry Thought Leadership

Contact